Subcutaneous Four-Week Dosing of the Novel Protein S Antibody VGA039 Demonstrates Safety and Clinically Meaningful Bleed Reduction in Patients with Von Willebrand Disease: Phase 1/2 Multi-Dose Study Results
Nicoletta C. Machin, Shrinath Kshirsagar, Adam Giermasz, Johnny Mahlangu, Gabriela Yamaguti-Hayakawa, Savita Rangarajan, Genevieve Moyer, Christine Kempton, Jane Mason, Michelle Sholzberg, Paula Villaça, Sandip Panicker, Eileen K. Sawyer, Gary Patou, Benjamin Kim, Allison P. Wheeler
Session: Short Talks - Emerging Therapeutics and Prophylactic Strategies in Coagulation Disorder
- Short Talks (Live Event)
|
Biliary Events in the Fitusiran Clinical Development Program With the Antithrombin-Based Dose Regimen
Mindy Simpson, Canan Albayrak, Savita Rangarajan, Oleksandra Stasyshyn, Jing Sun, Chur-Woo You, Abhimanyu Yarramaneni, Laurel A. Menapace, Yuqian Shen, Kaan Kavakli
Session: Posters/Exhibits/Break
- Posters/Exhibits/Break (On-Demand)
|
